Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -10.265% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a: Cc1cc(NC(=O)C2CCN(C(=O)c3ccco3)CC2)ccc1Br
b: COc1ccc2nc3ccccc3nc2c1
c: O=C1CC(c2cccc([N+](=O)[O-])c2)c2c(ccc3ccccc23)N1
d: CC1CN(C(=O)CSc2nc(N)cc(N)n2)CC(C)O1
Answer: d. CC1CN(C(=O)CSc2nc(N)cc(N)n2)CC(C)O1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CN(C(=O)CSc2nc(N)cc(N)n2)CC(C)O1
CC1CN(C(=O)CSc2nc(N)cc(N)n2)CC(C)O1
2-(4,6-diaminopyrimidin-2-yl)sulfanyl-1-(2,6-dimethylmorpholin-4-yl)ethanone